메뉴 건너뛰기




Volumn 85, Issue 3, 2001, Pages 539-543

Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban

Author keywords

Anticoagulants; Ca2+ chelation; GPIIb IIIa antagonists; Platelet aggregation

Indexed keywords

ABCIXIMAB; CALCIUM ION; CITRATE TRISODIUM; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TIROFIBAN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM; CHELATING AGENT; CITRIC ACID; DRUG DERIVATIVE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE; TYROSINE;

EID: 0035082570     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615618     Document Type: Article
Times cited : (32)

References (20)
  • 3
    • 0032485876 scopus 로고    scopus 로고
    • Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade
    • (1998) Circ , vol.97 , pp. 1680-1688
    • Mascelli, M.A.1
  • 4
    • 0028117857 scopus 로고
    • Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty
    • (1994) Circ , vol.90 , pp. 1757-1764
    • Tcheng, J.E.1
  • 10
    • 0021028111 scopus 로고
    • Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes
    • (1983) Biol Chem , vol.258 , pp. 10247-10252
    • Fujimura, K.1    Phillips, D.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.